Načítá se...
Cerebrospinal Fluid Biomarkers for Early and Differential Alzheimer’s Disease Diagnosis
An accurate and early diagnosis of Alzheimer’s disease (AD) is important to select optimal patient care and is critical in current clinical trials targeting core AD neuropathological features. The past decades, much progress has been made in the development and validation of cerebrospinal fluid (CSF...
Uloženo v:
| Vydáno v: | J Alzheimers Dis |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
IOS Press
2018
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5870045/ https://ncbi.nlm.nih.gov/pubmed/29562530 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3233/JAD-170680 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|